The global probiotics market is experiencing robust growth and is projected to expand significantly over the next decade. Estimated at $70.9 billion in 2024, the market is forecasted to reach $165.1 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.0% during this period[1][5].

Market Growth Drivers

This growth is driven by increasing health and fitness awareness among consumers, innovations in probiotic strains and products, and a rising focus on personalized nutrition, including nutrigenomics and nutrigenetics. The COVID-19 pandemic has further accelerated demand for probiotic supplements due to heightened health consciousness and preventive healthcare benefits. Regulatory advancements, such as the 2023 French approval allowing the use of the term "probiotic" on dietary supplement labels under specific conditions, have also propelled market expansion. Additionally, the ease of purchasing probiotics through online stores has improved accessibility and consumer choice[1].

Market Segmentation

The probiotics market is segmented by type, application, ingredient, end user, target population, distribution channel, and geography:

- By Type of Probiotic: Foods and beverages dominate the market share due to their accessibility, affordability, and nutritional value. Probiotic dietary supplements are expected to witness substantial growth, with a CAGR around 8.9% forecasted. Other segments include animal feed and other probiotics[5].

- By Type of Food and Beverage: Fermented foods, such as yogurt and sauerkraut, hold the largest share (~40%) of the market and are projected to grow significantly. The market also includes beverages, dry foods, dairy products, and non-dairy products, with non-dairy functional foods and beverages expected to grow at a higher CAGR[1][5].

- By Type of Probiotic Dietary Supplement: Nutritional supplements currently dominate, driven by consumer demand for health benefits. Specialty supplements are anticipated to grow rapidly (CAGR of 9.6%), with companies actively developing new strains. Infant formula and other probiotic supplements are also part of this segment[1][5].

- By Ingredient: Probiotic bacteria generate the majority of market revenues and are expected to maintain dominance over yeast-based probiotics[1].

- By End User: The human segment holds the majority share compared to animal probiotics, a trend expected to continue through 2035[1].

- By Target Human Population: Adults account for approximately 80% of the market, though the children/infants segment is expected to grow at a relatively higher CAGR during the forecast period[1].

- By Distribution Channel: Hypermarkets and supermarkets currently lead in probiotic sales due to easy access to diverse probiotic foods and supplements. Online stores are expected to experience high growth, enhancing product accessibility and consumer convenience[1].

- By Geography: Asia-Pacific commands the largest market share (47%), attributed to high consumer acceptance and preventive healthcare focus. North America follows, with strong awareness and availability of probiotic products. The Middle East and North Africa region is projected to grow at a relatively high CAGR through 2035[1].

Applications and Benefits

Probiotics are live, non-pathogenic microorganisms that confer health benefits by restoring gut microflora balance, which supports digestive health and immunity. They are used in various formats, including fermented foods, functional foods, dietary supplements, and animal feed. Probiotics contribute to improved gut, oral, mental, vaginal, and skin health, and are recommended for infants to alleviate gastrointestinal issues and colic. The scientific community continues to explore their role in preventing and treating various health conditions. Probiotics are part of a broader microbiome therapeutics class, including prebiotics, fecal microbiota transplantation, live biotherapeutics, and postbiotics. The synergistic combination of probiotics and prebiotics (symbiotics) enhances gut bacterial balance[1].

Market Drivers and Innovation

Key drivers include the development of novel and complex probiotic strains beyond traditional species like Lactobacillus and Bifidobacterium. Next-generation and genetically modified probiotics offer safer, targeted treatment options. The trend toward personalized nutrition and precision medicine fuels probiotic adoption as interventions to modify microbiome profiles for long-term health benefits. Companies are investing heavily in research and development to create specialized probiotics, often combining them with prebiotics or fibers to enhance efficacy[1].

Competitive Landscape

The market features prominent players such as AB-BIOTICS, ADM, Arla Foods, BioGaia, Danone, General Mills, i-Health, IFF, Kerry, Lallemand, Lifeway Foods, Meiji, Morinaga Milk, Mother Dairy, Nestlé, Novonesis, Probi, Velbiom, Winclove Probiotics, and Yakult Honsh

Thank you for reading Roots Analysis report. Kindly get in touch with Roots’ team to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact Details

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/